Protalix BioTherapeutics, Inc. (DE) (PLX): Price and Financial Metrics

PLX POWR Grades

• PLX scores best on the Sentiment dimension, with a Sentiment rank ahead of 86.08% of US stocks.
• PLX's strongest trending metric is Stability; it's been moving down over the last 177 days.
• PLX's current lowest rank is in the Stability metric (where it is better than 18.85% of US stocks).

PLX Stock Summary

• The capital turnover (annual revenue relative to shareholder's equity) for PLX is -4.13 -- better than merely 3.26% of US stocks.
• Of note is the ratio of PROTALIX BIOTHERAPEUTICS INC's sales and general administrative expense to its total operating expenses; merely 12.5% of US stocks have a lower such ratio.
• Equity multiplier, or assets relative to shareholders' equity, comes in at -7.43 for PROTALIX BIOTHERAPEUTICS INC; that's greater than it is for merely 2.84% of US stocks.
• Stocks with similar financial metrics, market capitalization, and price volatility to PROTALIX BIOTHERAPEUTICS INC are PULM, HYLN, SYBX, DBVT, and TCRX.
• PLX's SEC filings can be seen here. And to visit PROTALIX BIOTHERAPEUTICS INC's official web site, go to www.protalix.com.

PLX Valuation Summary

• PLX's price/sales ratio is 1.8; this is 12.2% lower than that of the median Healthcare stock.
• Over the past 243 months, PLX's price/sales ratio has gone NA NA.

Below are key valuation metrics over time for PLX.

PLX Growth Metrics

Its 2 year net cashflow from operations growth rate is now at 67.29%.
• Its 5 year net income to common stockholders growth rate is now at 88.31%.
• Its 4 year net cashflow from operations growth rate is now at 37.87%.

PLX's revenue has moved up $37,879,000 over the prior 49 months.

The table below shows PLX's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	47.57	-27.476	-17.854
2022-06-30	45.441	-20.152	-18.486
2022-03-31	43.115	-6.28	-24.393
2021-12-31	38.35	-10.285	-27.582
2021-09-30	49.296	-12.748	-20.518
2021-06-30	48.032	-14.472	-20.756

PLX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• PLX has a Quality Grade of C, ranking ahead of 73.31% of graded US stocks.
• PLX's asset turnover comes in at 0.547 -- ranking 71st of 681 Pharmaceutical Products stocks.
• MNKD, XTNT, and NBIX are the stocks whose asset turnover ratios are most correlated with PLX.

The table below shows PLX's key quality metrics over time.